214 related articles for article (PubMed ID: 7542859)
1. Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).
Sciarra F
Ann N Y Acad Sci; 1995 Jun; 761():66-78. PubMed ID: 7542859
[TBL] [Abstract][Full Text] [Related]
2. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
[TBL] [Abstract][Full Text] [Related]
3. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
Monti S; Sciarra F; Adamo MV; Toscano V; Trotta MC; Martini C; Lanzara S; Silverio FD
J Androl; 1997; 18(5):488-94. PubMed ID: 9349746
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasia.
Lubrano C; Petrangeli E; Catizone A; Santonati A; Concolino G; Rombolá N; Frati L; Di Silverio F; Sciarra F
J Steroid Biochem; 1989; 34(1-6):499-504. PubMed ID: 2483222
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.
Yang Y; Chisholm GD; Habib FK
Br J Cancer; 1993 Jan; 67(1):152-5. PubMed ID: 7678977
[TBL] [Abstract][Full Text] [Related]
6. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
Trachtenberg J; Hicks LL; Walsh PC
J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
[TBL] [Abstract][Full Text] [Related]
7. Benign prostatic hyperplasia--video image analysis and its relationship to androgen and epidermal growth factor receptor expression.
Frydenberg M; Foo TM; Jones AS; Grace J; Hensley WJ; Rogers J; Pearson BS; Raghavan D
J Urol; 1991 Sep; 146(3):872-6. PubMed ID: 1714972
[TBL] [Abstract][Full Text] [Related]
8. Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.
de Jong FH; Reuvers PJ; Bolt-de Vries J; Mulder E; Blom JH; Schroeder FH
J Steroid Biochem Mol Biol; 1992 Mar; 42(1):49-55. PubMed ID: 1373073
[TBL] [Abstract][Full Text] [Related]
9. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
[TBL] [Abstract][Full Text] [Related]
10. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
Ghanadian R; Puah CM
J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptors.
Lubrano C; Sciarra F; Spera G; Petrangeli E; Toscano V; Rombola N; Palleschi F; Palma E; Di Silverio F
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):683-7. PubMed ID: 1373303
[TBL] [Abstract][Full Text] [Related]
12. Endogenous androgen levels in epithelium and stroma of human benign prostatic hyperplasia and normal prostate.
Bartsch W; Krieg M; Becker H; Mohrmann J; Voigt KD
Acta Endocrinol (Copenh); 1982 Aug; 100(4):634-40. PubMed ID: 6181638
[TBL] [Abstract][Full Text] [Related]
13. Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP.
Ravenna L; Lubrano C; Di Silverio F; Vacca A; Felli MP; Maroder M; D'Eramo G; Sciarra F; Frati L; Gulino A
Prostate; 1995 Jun; 26(6):290-8. PubMed ID: 7784269
[TBL] [Abstract][Full Text] [Related]
14. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
15. Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia.
Lubrano C; Toscano V; Petrangeli E; Spera G; Trotta MC; Rombolà N; Frati L; Di Silverio F; Sciarra F
J Steroid Biochem Mol Biol; 1993 Oct; 46(4):463-8. PubMed ID: 7692939
[TBL] [Abstract][Full Text] [Related]
16. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
17. Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH).
Monti S; Di Silverio F; Toscano V; Martini C; Lanzara S; Varasano PA; Sciarra F
J Androl; 1998; 19(4):428-33. PubMed ID: 9733145
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
Krieg M; Bartsch W; Janssen W; Voigt KD
J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
[No Abstract] [Full Text] [Related]
19. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
Mukherjee B; Mayer D
Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894
[TBL] [Abstract][Full Text] [Related]
20. Subnormal tissue 3 alpha-androstanediol and androsterone in prostatic hyperplasia.
Meikle AW; Stringham JD; Olsen DC
J Clin Endocrinol Metab; 1978 Oct; 47(4):909-13. PubMed ID: 95628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
